Outcomes of patients receiving direct oral anticoagulants for myeloproliferative neoplasm‐associated venous thromboembolism in a large tertiary centre in the UK
Natalia Curto‐García(Guy's and St Thomas' NHS Foundation Trust), Claire Harrison(Guy's and St Thomas' NHS Foundation Trust), Beverley J. Hunt(Guy's and St Thomas' NHS Foundation Trust), Karen Breen(Guy's and St Thomas' NHS Foundation Trust), Andrew J. Doyle(St Thomas' Hospital), Donal P. McLornan(King's College London), Gavin Ling(Guy's and St Thomas' NHS Foundation Trust), Deepti Radia(St Thomas' Hospital)
Cited by 31
Related Papers
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
Somatic <i>CALR</i> Mutations in Myeloproliferative Neoplasms with Nonmutated <i>JAK2</i>
|New England Journal of Medicine|2013|1.7k
The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition
|Critical Care|2016|1.5k